Published Online
on June 30, 2008

A more recent version of this article appeared on July 8, 2008

This Article Full Text (PDF) Data Supplement All Versions of this Article: 118/2/166    most recent CIRCULATIONAHA.107.758516v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eckle, T. Articles by Eltzschig, H. K. Search for Related Content PubMed PubMed Citation Articles by Eckle, T. Articles by Eltzschig, H. K. Related Collections Animal models of human disease Physiological and pathological control of gene expression Acute myocardial infarction Receptor pharmacology Related Article

Submitted on December 5, 2007
Accepted on April 25, 2008

Hypoxia-Inducible Factor-1 Is Central to Cardioprotection. A New Paradigm for Ischemic Preconditioning

Tobias Eckle MD, PhD, David Köhler PhD, Rainer Lehmann MD, PhD, Karim C. El Kasmi MD, PhD, and Holger K. Eltzschig MD, PhD^*

From the Department of Anesthesiology and Intensive Care Medicine (T.E., D.K., H.K.E.), and Department of Internal Medicine 4, Division of Clinical Chemistry (R.L.), University Hospital, Tübingen, Germany; and Mucosal Inflammation Program, Department of Anesthesiology and Perioperative Medicine, University of Colorado Health Science Center, Denver (T.E., K.C.E.K., H.K.E.).

^* To whom correspondence should be addressed. E-mail: holger.eltzschig{at}uchsc.edu.

Background—Ischemic preconditioning provides strong cardioprotection from ischemia, but its molecular mechanisms remain unknown. Convincing evidence confirms a central role of hypoxia-inducible factor (HIF)-1 in mammalian oxygen homeostasis. Thus, we pursued HIF-1 as a central component of cardioprotection by ischemic preconditioning.

Methods and Results—Murine studies of in situ preconditioning revealed a robust activation of cardiac HIF-1. Moreover, in vivo small interfering RNA repression of cardiac HIF-1 resulted in abolished cardioprotection by ischemic preconditioning. In contrast, pretreatment with the HIF activator dimethyloxalylglycine was associated with cardioprotection similar to that of ischemic preconditioning itself. Finally, selective small interfering RNA repression of prolylhydroxylase 2 resulted in significant activation of HIF-1 and attenuated myocardial infarct sizes (0.44±0.09-fold). As an end point of HIF-dependent cardioprotection, we defined the role of A2B adenosine receptor (A2BAR) signaling. Although the cardiac A2BAR was induced with HIF activation, HIF-dependent cardioprotection was abolished in A2BAR^-/- mice.

Conclusion—Taken together, these studies provide evidence for a critical role of HIF-1 in ischemic preconditioning via enhancing purinergic signaling pathways.

Key words: adenosine • hypoxia-inducible factor 1 • ischemia • ischemic preconditioning • myocardial infarction

Related Article:

Clinical Summaries
Circulation 2008 118: 105-106. [Extract] [Full Text]

This article has been cited by other articles:

				T. Eckle, M. Koeppen, and H. K. Eltzschig Role of Extracellular Adenosine in Acute Lung Injury Physiology, October 1, 2009; 24(5): 298 - 306. [Abstract] [Full Text] [PDF]

				H. Zhao, Y. Wang, Y. Wu, X. Li, G. Yang, X. Ma, R. Zhao, and H. Liu Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1{alpha} upregulation Acta Biochim Biophys Sin, September 1, 2009; 41(9): 745 - 753. [Abstract] [Full Text] [PDF]

				S. Frede, C. Stockmann, S. Winning, P. Freitag, and J. Fandrey Hypoxia-Inducible Factor (HIF) 1{alpha} Accumulation and HIF Target Gene Expression Are Impaired after Induction of Endotoxin Tolerance J. Immunol., May 15, 2009; 182(10): 6470 - 6476. [Abstract] [Full Text] [PDF]

				J.-S. Frick, C. F. MacManus, M. Scully, L. E. Glover, H. K. Eltzschig, and S. P. Colgan Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis J. Immunol., April 15, 2009; 182(8): 4957 - 4964. [Abstract] [Full Text] [PDF]

				S. Rane, M. He, D. Sayed, H. Vashistha, A. Malhotra, J. Sadoshima, D. E. Vatner, S. F. Vatner, and M. Abdellatif Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1{alpha} and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes Circ. Res., April 10, 2009; 104(7): 879 - 886. [Abstract] [Full Text] [PDF]

				J. H. Indik, R. W. Hilwig, M. Zuercher, K. B. Kern, M. D. Berg, and R. A. Berg Preshock Cardiopulmonary Resuscitation Worsens Outcome From Circulatory Phase Ventricular Fibrillation With Acute Coronary Artery Obstruction in Swine Circ Arrhythm Electrophysiol, April 1, 2009; 2(2): 179 - 184. [Abstract] [Full Text] [PDF]

				J. Reutershan, I. Vollmer, S. Stark, R. Wagner, K.-C. Ngamsri, and H. K. Eltzschig Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs FASEB J, February 1, 2009; 23(2): 473 - 482. [Abstract] [Full Text] [PDF]

				H. K. Eltzschig, D. Kohler, T. Eckle, T. Kong, S. C. Robson, and S. P. Colgan Central role of Sp1-regulated CD39 in hypoxia/ischemia protection Blood, January 1, 2009; 113(1): 224 - 232. [Abstract] [Full Text] [PDF]